dub-K

Enjoy the under appreciated art of biotechnology. Let’s save lives from these terrible diseases.

[zohm @zohmbastic]

$FIG
RBC Capital raised the firm's price target on Figma to $28 from $22 and keeps a Sector Perform rating on the shares.

[dub-K @dub_k1]

@hbtCHIEFS Chiefs 27 - broncos 17

[Chief-Biotech @ChiefBiotech]

Good to see $PDSB management addressing the main bear point of the shorts of how OS isn’t real due to censored patients. Yet the statistical experts after obtaining survival & disease progression records found no negative impact on PFS & OS.

[dub-K @dub_k1]

Top bio gainers of the year are $RGLS & $ABVX & both are micro RNA company’s. $RNAZ is the only other micro RNA company left & just secured $25M with $12M mcap.

[OdaSkillsInvests @OdaSkillsInvest]

$RNAZ 🚀 #News : Acquires Polynoma + $25M financing from CK Life Sciences! 📈 Immuno-oncology powerhouse—Phase III vaccine + TTX-MC138. Vol 1.46M spiking, broke $12—eyes $20+? Low float 832K = squeeze! 🔥 Broker SS/ chart below. #RNAZ #Biotech #PennyStocks #ImmunoOncology 🩺⚕️🍿

[dub-K @dub_k1]

$PYXS

[LARVOL @Larvol]

On Head and Neck Cancer Day, we’re sharing key anticipated milestones expected in 2025.

🔗 Follow us for latest clinical trials and insights from the world of oncology 👉 https://t.co/MYJm2NGHs1

#LARVOL #CancerResearch #Oncology #ClinicalTrials #CancerData #OncologyInsights #HeadandNeckCancer #HNC | @CJTsaiMDPhD | @Timothee_MD | @PaulJiL | @DavidSherMD | @DrMLChua | @rbryanbell | @xrtGenomics | @SuyogCancer

[dub-K @dub_k1]

@Sanctuary_Bio @JoseRestonVA @synapse_surfer Curious what ur thoughts on MRUS claiming that their drug works on HPV16+ H&N while that’s considered a completely different disease than HPV-. BCAX isn’t even going after HPV+ pt’s because EGFR’s are not meant to work in that population.
Also pembro’s recent approval in neo-adj

[dub-K @dub_k1]

$RNAZ - low float MicroRNA who just brought on the founder of $ALNY onto their board in May.

[Adam May @A_May_MD]

Time stamped. $ABVX $RGLS.
#1 #2
#LongLiveMicroRNA
#BioPick @pawcio2009 @seedy19tron

[dub-K @dub_k1]

Top bio gainers of the year $RGLS & $ABVX are both Micro RNA. Only other name that I could find that’s same sector is $RNAZ $10m mcap(LOW float). They just brought on founder of $ALNY on their board. Could this move like $TIL after $SMMT news?

[dub-K @dub_k1]

@jfais20 @TOWiU2 “Adam F, who I normally trust” HA! All that means, is you just haven’t invested in a name that was his target.He goes on personal crusades to pump out half-truths & misinfo to hurt the name as much as possible.He’s not always wrong but he isn’t a fair reporter that he pretends 2B

[dub-K @dub_k1]

@AscendingBio It’s nice to see that they’re expecting recruitment completion by Q4. Hopefully all the NCI studies keep pumping data out every few months.🤞🏾

[dub-K @dub_k1]

@AscendingBio Really appreciate your breakdowns! 🙏🏾

Enjoy the long wknd!

[dub-K @dub_k1]

@A_May_MD Or they actually mean what they say here & are deep in conversations to partner for phase 3 & are more focused on closing that than raising any funds.

They have solid history of partnerships with many BP.

[dub-K @dub_k1]

Each passing day $NKTR doesn’t raise $, the more exciting this statement by CEO becomes. Have strong track record of partnerships with BP(8). $AMGN $AZN $BMY $LLY $PFE $TAK
Not their 1st Rodeo! “So stay Tuned!”

[dub-K @dub_k1]

$NKTR - “We’re also talking to number of potential partners & collaborators to help us with P3.”

Next sentence is key “So stay tuned for that.” I really like the sound of that.

[dub-K @dub_k1]

$CMPS

[Lauren Gardner @Gardner_LM]

NEW: @US_FDA alum Mike Davis to rejoin agency as deputy director of the drug center. He previously worked in CDER's psychiatry division and most recently worked at a nonprofit developing psychedelic drugs for depression https://t.co/TGyqZJmPHj

[dub-K @dub_k1]

$CMPS

[dub-K @dub_k1]

@adamfeuerstein @Sanctuary_Bio It’s funny how you guys always look down at & shit on retail investors. Then u guys bitch & complain why ur favourite bio is worth peanuts while Fartcoin is worth $1B+. This snobby attitude is exactly what turns ppl off.Retail has a lot of $$ but y’all would rather look cool on X

[dub-K @dub_k1]

$NKTR - just broke high of the day which happened at open. Now that all the retail that was in rush to take profit is gone. Let them chase now. Too much upside potential in next 6 months with big catalysts.

Next key level would be to break premarket highs 🙏🏾

[dub-K @dub_k1]

$NKTR - “We’re also talking to number of potential partners & collaborators to help us with P3.”

Next sentence is key “So stay tuned for that.” I really like the sound of that.

[dub-K @dub_k1]

$NKTR if it breaks $20 - massive potential of a squeeze 🙏🏾🙏🏾

[dub-K @dub_k1]

$NKTR - “We’re also talking to number of potential partners & collaborators to help us with P3.”

Next sentence is key “So stay tuned for that.” I really like the sound of that.

[dub-K @dub_k1]

@Sanctuary_Bio Might be but if they don’t raise any money tonight or do just a small raise, then this becomes a lot more exciting statement. 🤨

[dub-K @dub_k1]

$NKTR - “We’re also talking to number of potential partners & collaborators to help us with P3.”

Next sentence is key “So stay tuned for that.” I really like the sound of that.